Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

<< Previous

Bullboard Posts

Next >>

Post by blackredblackon Jan 13, 2021 3:32pm

271 Views

Post# 32287083

Seeking APHA Earnings review

Aphria Q2 2021 Earnings Preview

Jan. 13, 2021 1:58 PM ETAphria Inc. (APHA)By: Akanksha Bakshi, SA News Editor6 Comments

Aphria (OTC:APHA) is scheduled to announce Q2 earnings results on Thursday, January 14th, before market open.
The consensus EPS Estimate is -C$0.03 (flat Y/Y) and the consensus Revenue Estimate is C$153.7M (+27.4% Y/Y).
Analysts expect adj. EBITDA of C$11.4M.
Over the last 1 year, APHA has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 1 downward. Revenue estimates have seen 1 upward revision and 6 downward.